AMC vs IMAX: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
AMC and IMAX are similarly sized, but IMAX trades noticeably cheaper on forward earnings (21.39x vs 40.74x): the market is paying up for AMC's profile and pricing IMAX more conservatively, or for faster growth. Which you prefer comes down to the drivers you believe, and whether adding either over-concentrates what you already own.
AMC vs IMAX: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | AMC | IMAX | What it tells you |
|---|---|---|---|
| Market cap | $3.03B | $2.68B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 40.74 | 21.39 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 2.24 | 0.51 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 87% of range | 63% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
Reading it: IMAX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how AMC and IMAX affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AMC and IMAX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AMC and IMAX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does AMC Entertainment (AMC) do?
AMC Entertainment Holdings, Inc. (NYSE: AMC), headquartered in Leawood, Kansas, is the largest movie-theater exhibitor in the United States and the world, operating theatres across the U.S. and Europe under the AMC, Odeon, and other banners. The company makes money primarily from box-office admissions and from high-margin food and beverage sales, supplemented by on-screen advertising and premium formats. Its results are tightly tied to the strength of the theatrical film slate: a strong year of major releases lifts attendance and revenue, while a thin or delayed slate (as during the pandemic and the 2023 Hollywood strikes) can sharply reduce both. Full-year 2025 revenue was approximately $4.85 billion (up about 4% from 2024) with a net loss of about $632 million. The recovery picked up in 2026: Q1 revenue grew approximately 21% year over year to about $1.05 billion, and Q2 revenue rose about 14% to roughly $1.6 billion, with adjusted EBITDA up about 70% to roughly $321 million, free cash flow of about $190 million, and a net loss that shrank to about $11 million. Q2 EPS of $0.14 came in well above the roughly $0.03 consensus.
What does IMAX Corporation (IMAX) do?
IMAX Corporation designs and markets premium large-format cinema systems and licenses proprietary technology that lets studios remaster films into the IMAX format. Rather than owning most theaters itself, IMAX runs an asset-light model: it sells or leases its projection and sound systems to exhibitor partners, then earns ongoing revenue tied to ticket sales through revenue-share and joint-venture arrangements. Its two reporting segments are Technology Products and Services (the systems, maintenance, and network operations) and Content Solutions (film remastering, distribution, and the growing slate of local-language titles). By 2025 the IMAX network spanned more than 1,700 theaters globally, larger than rival premium formats.
AMC vs IMAX: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- AMC drivers: Box-Office Recovery and Film Slate; Premium Formats and Concessions.
- IMAX drivers: Record box office and premium share; Local-language content expansion.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The dominant risk is the balance sheet: AMC carried roughly $3.85 billion in corporate borrowings (about $7.7 billion of total debt including leases) against about $778 million of cash and a stockholders' deficit near $1.45 billion as of mid-2026, so interest costs and refinancing needs weigh heavily on the equity even after the October refinancing. For IMAX, iMAX's results depend heavily on the theatrical film release calendar, which it does not control, so a weak slate of major titles in any period can pressure box office and revenue.
AMC or IMAX: which should you pick?
AMC vs IMAX: the full fundamentals
AMC. AMC's valuation is unusual because the equity story is driven heavily by debt and dilution rather than by a simple multiple of earnings. The company is still not profitable on a trailing net-income basis, so the relevant lens is enterprise value relative to a cash flow that turned positive in mid-2026 (EV/EBITDA near 16.5x), against roughly $3.85 billion of corporate borrowings and a stockholders' deficit. After an 85% rally in 2026 the shares sit just below the roughly $3.20 average analyst target with a consensus hold, and the Q3 report on October 20, 2026 (consensus about $0.10 EPS on $1.52 billion revenue) is the next test. The stock's price has also historically reflected retail sentiment and short interest tied to its meme-stock status, which can decouple it from fundamentals in both directions.
IMAX. The gap between a trailing P/E near 72 and a forward P/E near 24 is the whole valuation debate: the market is paying for a 2026 in which consensus EPS rises to about $2.07 on revenue of about $471 million, driven by a record third quarter. The shares are up about 44% year to date and 64% over a year, close to the $57.50 average analyst target, so the late-October report and any update to box office guidance carry a lot of weight.
Headline figures (approximate, October 2026): AMC shows revenue (ttm) ~$5.23 billion; Q2 2026 ~$1.6 billion (up ~14% YoY), revenue (fy2025) ~$4.85 billion (up ~4% YoY), adjusted ebitda (q2 2026) ~$321 million (up ~70% YoY), net loss (ttm) ~$554 million; Q2 2026 net loss narrowed to ~$11 million; IMAX shows revenue (ttm to june 2026) ~$416 million; Q2 2026 revenue ~$103 million, up ~12% year over year, margins (ttm) Gross ~60%, operating ~23%, net ~10%, net income / eps (ttm) ~$41 million net income; GAAP EPS ~$0.72; forward EPS estimate ~$2.16, p/e ~72x trailing, ~24x forward.
The bottom line: AMC vs IMAX
AMC and IMAX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AMC and IMAX exposure against your real portfolio. It is not an investment adviser.
Wondering how AMC or IMAX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about AMC Entertainment
Ask Walnut's AI anything about AMC and see how it fits what you own.
FAQ
What is the difference between AMC and IMAX?
+
AMC Entertainment Holdings, Inc. IMAX Corporation designs and markets premium large-format cinema systems and licenses proprietary technology that lets studios remaster films into the IMAX format. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is AMC or IMAX the better stock?
+
Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, AMC or IMAX?
+
On forward P/E (as of November 2026), AMC trades at 40.74x and IMAX at 21.39x, so IMAX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both AMC and IMAX?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of AMC vs IMAX?
+
AMC: The dominant risk is the balance sheet: AMC carried roughly $3.85 billion in corporate borrowings (about $7.7 billion of total debt including leases) against about $778 million of cash and a stockholders' deficit near $1.45 billion as of mid-2026, so interest costs and refinancing needs weigh heavily on the equity even after the October refinancing. Dilution is a second, recurring risk; the share count has grown by hundreds of millions over the past few years through repeated equity sales, including offerings in 2026, which mechanically reduces value per share even when the business improves. The company still lost about $554 million over the last twelve months on a GAAP basis. The secular shift toward streaming and shortened theatrical windows pressures long-run theater demand, and attendance is volatile and dependent on a film slate AMC does not control, so a weak release year can quickly reverse the recovery. After an 85% rise in 2026 the stock trades just below the roughly $3.20 average analyst target, and the meme-stock legacy means the share price can move on retail sentiment and short interest rather than fundamentals. IMAX: IMAX's results depend heavily on the theatrical film release calendar, which it does not control, so a weak slate of major titles in any period can pressure box office and revenue. Greater China is a swing market: IMAX box office there plunged roughly 62% in the first quarter of 2026 against a very strong prior-year period, showing how concentrated and volatile that geography can be. Competition from Dolby Cinema, Cinemark XD, Regal RPX, ScreenX, 4DX, and exhibitors' own premium-format brands is intensifying, and some operators resent the revenue cut IMAX takes. Longer term, the shift toward streaming and shorter theatrical windows could erode moviegoing, and at a trailing price-to-earnings multiple around 72x (about 24x forward) the stock prices in continued record performance, leaving it exposed if growth slows. Consensus calls for 2027 revenue growth of only about 6.5% after an expected 43% jump in 2026 EPS, so a year without an Odyssey-sized release would make comparisons harder.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AMC or IMAX; figures are approximate and dated (as of November 2026). Verify current data before investing.